|
Establishment Of A Head And Neck Cancer Tissue/Specimen Bank
Patients must have a suspected or confirmed diagnosis of head
and neck cancer and must be potentially eligible for an active
RTOG treatment study. Patients with biopsy proven recurrent cancer
at the primary site also are eligible if they are potentially eligible
for an RTOG treatment study for patients with recurrent disease
or if they fail on an RTOG treatment study which collects specimens
at the time of recurrence. Zubrod Performance Status 0-1; Age > 18;
Patient must sign a study specific informed consent for RTOG 0514.
N/A, Ongoing Prospective Tissue/Specimen Bank
Research Study
<< Back to Clinical
Trials Main Page >>
[ top ] |
